Biguanide derivative and therapeutic agent for diabetes containing the same
US7396858B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2003 |
| Grant date | Jul 8, 2008 |
| Priority date | — |
| Expiry date | Apr 5, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Diabetes treatments comprising, as effective ingredients, biguanide derivatives represented by the following general formula (1), or salts thereof.(wherein R1, R2 and R3 may be the same or different and each represents one selected from the group consisting of hydrogen, optionally substituted lower alkyl groups and optionally substituted lower alkylthio groups).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.